Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

menarini international operations luxembourg s.a. - deksketoprofenas - geriamasis tirpalas paketėlyje - 12,5 mg; 50 mg/2 ml; 25 mg - dexketoprofen

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

astrazeneca ab - durvalumab - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

tojaris projektai, uab - meloksikamas - injekcinis tirpalas - 15 mg/1,5 ml - meloxicam

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

lex ano, uab - lornoksikamas - plėvele dengtos tabletės - 8 mg - lornoxicam

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

lex ano, uab - metotreksatas - tabletės - 5 mg - methotrexate

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

sopharma ad - deksketoprofenas - injekcinis ar infuzinis tirpalas - 25 mg/2 ml - dexketoprofen

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - krūties navikai - antinavikiniai vaistai - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

dompe farmaceutici s.p.a - ketoprofenas - dengtos granulės paketėlyje - 25 mg - ketoprofen

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

dompe farmaceutici s.p.a - ketoprofenas - plėvele dengtos tabletės - 25 mg - ketoprofen

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

menarini international operations luxembourg s.a. - deksketoprofenas - granulės paketėlyje - 25 mg - dexketoprofen